CHAPEL HILL, N.C., Oct. 28, 2011 /PRNewswire/ -- The oncology market continues to be a rapid growth area for the pharmaceutical industry. Managing all the aspects of successfully launching a new oncology product is a daunting endeavor that often falls to the Global Strategic Marketing function.
The regulatory environment, regional differences and the competitive nature of the oncology marketplace present significant challenges for Global Strategic Marketing (GSM) organizations. The evolving nature of these challenges pushes GSM organizations to continually assess their budgets, investment strategies, staffing, structure and scope of services.
For instance, a survey of 12 large pharmaceutical companies found a majority expected to increase spending for four of six GSM activities for pipeline products over the next two years. Activities expected to gain are ad boards, marketing, thought leaders and market intelligence. Meanwhile, most of the companies expect spending to stay flat or drop for global congresses/conventions during the same period, according to a new benchmarking study from Best Practices, LLC.
The study, Oncology Global Strategic Marketing: Benchmarking Budget Levels and Service Scope, was designed to help GSM leaders in oncology better evaluate and improve their global strategic marketing programs. This 75-page study provides current benchmarks such as:
Page: 1 2 Related medicine technology :1
- GSM staffing benchmarks by role, by development phase, by number of oncology programs and per $100M in oncology sales
- Outsourced and in-house labor dedicated to traditional and emerging markets
- GSM organizational structure
- Role of the GSM function for activities such as market intelligence, marketing, advocacy and KOL management
- Spending benchmarks around key GSM activities within marketing, market intelligence and advocacy
- Oncology GSM spendin
. Hypertronics Partners with UBM Canon, the Leading Global Medical Device Industry Source, to Co-Host Strategies for Avoiding Device Failure Seminar2
. Global Pharm Announces the Closing of US$15 Million Redeemable Convertible Bonds Financing3
. Global Eyeglasses Industry4
. S*BIO to Initiate Global Phase 3 Clinical Trials of its Novel JAK2 Inhibitor Pacritinib for Treatment of Myelofibrosis (MF)5
. CPhI Global Portfolio Expands into South East Asia6
. Gastric Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume I 20117
. MarketsandMarkets: Global Orthopedic Devices Market Expected to Reach $57.9 Billion by 20168
. White Smile Global Inc. Proudly Announces the Introduction of a New Innovative White Smile® Professional™ Dental "In-Office" Teeth Whitening Kit9
. Intarcia and Quintiles Sign Letter of Intent for Innovative Global Collaboration to Advance ITCA 650 in Type 2 Diabetes10
. SPX to Acquire e&e, a Global Supplier of Extraction, Evaporation, Vacuum and Freeze Drying Technologies11
. Global Sources opens six trade shows with worlds top buyers registered to attend including Adidas, AEON, American Greetings, Brookstone, Casino, Coles Group, Mothercare, Next, Sears and Woolworths